PNC Managed Account Solutions’s Charles River Laboratories CRL Stock Holding History

PNC Managed Account Solutions’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3K	Buy	+8	New	+$2.67K	﹤0.01%	470

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PNC Managed Account Solutions's CRL Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Charles River Laboratories (CRL) in Q2 2021: 8 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #470 among its holdings.

638 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

PNC Managed Account Solutions held 8 shares of Charles River Laboratories worth $3K as of Q2 2021.
Charles River Laboratories was a new PNC Managed Account Solutions position in Q2 2021.
Charles River Laboratories made up ﹤0.01% of PNC Managed Account Solutions's portfolio in Q2 2021, its #470 holding.
638 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.